- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
SBC
NASDAQ
Week ended 31 Jul 2026
Weekly Investor Report
SBC Medical Group Holdings Incorporated · Industrials · Consulting Services
Latest close
3.06 USD
0.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -16.4% below the Trend Line and sits at 12.2% of its 52-week range. The latest completed week returned 0.0%, after a -5.8% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal; earnings are due in 10d.
Setup score
24
out of 100
Latest Close
3.06 USD
31 Jul 2026
1W Return
0.0%
latest completed week
4W Return
-5.8%
short-term follow-through
12W Return
-3.8%
quarterly tape
Trend Breadth
26.9%
14 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.0%
Latest completed week; four-week move -5.8%.
Indicator stack
15/41
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
45 relevant articles in the latest sentiment read.
Event risk
10d
Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -16.4% below the Trend Line and sits at 12.2% of its 52-week range. The latest completed week returned 0.0%, after a -5.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0512-week average 0.10
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.8% over four weeks, -3.8% over 12 weeks, and -26.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year14
Trend breadth26.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.55Latest activity-pressure read.
Pressure change15.3%Four-week change in activity pressure.
Leadership-27.35Latest relative-leadership reading.
RS change7.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 97%
Model confidence 93%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength87/100Blend of value, momentum, and quality. Underlying universe rank 14; rank 1 is best.
Value96/100Relative valuation strength. Underlying universe rank 5; rank 1 is best.
Quality86/100Profitability and accounting quality. Underlying universe rank 15; rank 1 is best.
Momentum10/100Medium-term price momentum. Underlying universe rank 91; rank 1 is best.
Growth6/100Revenue and earnings growth. Underlying universe rank 95; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 7.7x Price divided by trailing earnings.
- Price / sales
- 1.9x Market value relative to trailing revenue.
- EV / EBITDA
- 3.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 22.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 70.2% Gross profit retained from each unit of revenue.
- Operating margin
- 41.2% Operating profit retained from revenue.
- Free-cash-flow margin
- 28.6% Free cash flow generated from revenue.
- Return on invested capital
- 29.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -14.4% Latest one-year revenue growth.
- EPS growth
- -17.4% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 117.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 1.6% Net share repurchases relative to market value.
- Shareholder yield
- 1.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -1.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 45 relevant articles.
11 positive · 29 neutral · 5 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-39.6%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher10 of 2615 weeks finished lower.
Best week+12.9%Week of 3 Apr.
Worst week-25.4%Week of 24 Apr.
Latest week+0.0%Week of 31 Jul.
Shape of recent returns
Strong gains6
Modest gains4
Flat weeks1
Modest losses6
Sharp losses9
Recent vol5.1%13-week weekly-return volatility.
Base vol6.7%52-week weekly-return volatility.
Up/down split23/27Count of positive and negative weeks in the 52-week window.
Average skew5.4% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Industrials
4-week rank- / 100
Group average-3.6%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD54.0%positive activity pressure
RS53.0%positive relative leadership
Four-week leaders
IndustryUS Consulting Services
4-week rank16 / 20
Group average21.8%
Trend breadth30.0%
Trend30.0%active weekly trend signals
MD65.0%positive activity pressure
RS15.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape23/100
Trend, activity pressure, participation, and risk combine to a 23/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.05; No reversal markers Factors71/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 26; Small Cap Core rank 12 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 45 relevant articles.
SBC|SBC Medical Group Holdings Inc|Price:3.050|Chg%:-0.050 Insiders50/100No recent insider transaction evidence is stored.
Earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 3.06 USD | 0.0% | 3.66 USD | 4.46 USD | -0.55 | -27.35 | 406.0K | Off |
| 24 Jul 2026 | 3.06 USD | -0.6% | 3.70 USD | 4.48 USD | -0.71 | -27.66 | 293.3K | Off |
| 17 Jul 2026 | 3.08 USD | 3.7% | 3.75 USD | 4.49 USD | -0.57 | -29.22 | 286.4K | Off |
| 10 Jul 2026 | 2.97 USD | -8.6% | 3.80 USD | 4.51 USD | -0.61 | -35.71 | 674.9K | Off |
| 3 Jul 2026 | 3.25 USD | -1.5% | 3.84 USD | 4.52 USD | -0.65 | -29.45 | 289.4K | Off |
| 26 Jun 2026 | 3.30 USD | 7.5% | 3.85 USD | 4.54 USD | -0.70 | -28.49 | 1.6M | Off |
| 19 Jun 2026 | 3.07 USD | 7.0% | 3.86 USD | 4.55 USD | -0.89 | -37.18 | 316.6K | Off |
| 12 Jun 2026 | 2.87 USD | -4.7% | 3.87 USD | 4.57 USD | -0.96 | -40.41 | 366.8K | Off |
| 5 Jun 2026 | 3.01 USD | -6.2% | 3.88 USD | 4.58 USD | -0.92 | -36.87 | 721.0K | Off |
| 29 May 2026 | 3.21 USD | 4.6% | 3.89 USD | 4.60 USD | -0.94 | -36.55 | 637.7K | Off |
| 22 May 2026 | 3.07 USD | 3.4% | 3.89 USD | 4.62 USD | -0.86 | -38.52 | 606.2K | Off |
| 15 May 2026 | 2.97 USD | -6.6% | 3.91 USD | 4.64 USD | -0.68 | -40.57 | 877.1K | Off |
| 8 May 2026 | 3.18 USD | -3.9% | 3.95 USD | 4.66 USD | -0.38 | -36.98 | 415.2K | Off |
| 1 May 2026 | 3.31 USD | -1.2% | 3.98 USD | 4.67 USD | -0.13 | -31.24 | 865.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.